Serina Therapeutics Stock Analysis

Serina Stock Analysis Notes

About 58.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Serina Therapeutics had 28:1000 split on the 15th of March 2024. To find out more about Serina Therapeutics contact the company at 256 327 9630 or learn more at https://serinatherapeutics.com.

Serina Therapeutics Investment Alerts

Serina Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 57.2 M.

Serina Profitablity

The company has Net Profit Margin of (2.21) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (75.8) %, which entails that for every $100 of revenue, it lost $75.8.

Management Efficiency

Serina Therapeutics has Return on Asset of (0.4529) % which means that on every $100 spent on assets, it lost $0.4529. This is way below average. Serina Therapeutics' management efficiency ratios could be used to measure how well Serina Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 12/18/2024, Return On Tangible Assets is likely to drop to -1.37. In addition to that, Return On Capital Employed is likely to grow to -1.56. At this time, Serina Therapeutics' Total Assets are relatively stable compared to the past year. As of 12/18/2024, Non Current Assets Total is likely to grow to about 11.8 M, while Return On Tangible Assets are likely to drop (1.37).

Technical Drivers

As of the 18th of December 2024, Serina Therapeutics has the insignificant Risk Adjusted Performance, variance of 60.13, and Coefficient Of Variation of (5,360). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Serina Therapeutics, as well as the relationship between them. Please validate Serina Therapeutics risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Serina Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 4.79 per share. Given that Serina Therapeutics has information ratio of (0.03), we advise you to double-check Serina Therapeutics's current market performance to make sure the company can sustain itself at a future point.

Serina Therapeutics Price Movement Analysis

Serina Therapeutics Insider Trading Activities

Serina Therapeutics Predictive Daily Indicators

Serina Therapeutics Forecast Models

Serina Therapeutics' time-series forecasting models are one of many Serina Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Serina Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Serina Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Serina shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Serina Therapeutics. By using and applying Serina Stock analysis, traders can create a robust methodology for identifying Serina entry and exit points for their positions.

When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.